Related references
Note: Only part of the references are listed.TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE
Fei Liu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation
Kristin Baudiss et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslprlpr Mice
Qian Xin et al.
JOURNAL OF IMMUNOLOGY (2015)
Endogenous ligands of natural killer T cells are alpha-linked glycosylceramides
Lisa Kain et al.
MOLECULAR IMMUNOLOGY (2015)
Cognate interaction with iNKT cells expands IL-10-producing B regulatory cells
Emilie E. Vomhof-DeKrey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PRR-signaling pathways: Learning from microbial tactics
Gernot Sellge et al.
SEMINARS IN IMMUNOLOGY (2015)
Ceramides - Lipotoxic Inducers of Metabolic Disorders
Bhagirath Chaurasia et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Autoregulatory function of interleukin-10-producing pre-naive B cells is defective in systemic lupus erythematosus
Ji Hyun Sim et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity
Leonhard X. Heinz et al.
CELL REPORTS (2015)
Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus
Christian Lood et al.
PLOS ONE (2015)
The efficacy of novel B cell biologics as the future of SLE treatment: A review
Ameer Kamal et al.
AUTOIMMUNITY REVIEWS (2014)
Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients
Georgia McDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Sphingolipid metabolites in inflammatory disease
Michael Maceyka et al.
NATURE (2014)
Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus
H. Fan et al.
CELL DEATH & DISEASE (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages
Junfei Jin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
Jing Li et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Sphingolipid Signaling in Metabolic Disorders
Timothy Hla et al.
CELL METABOLISM (2012)
Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells
Anneleen Bosma et al.
IMMUNITY (2012)
Brief Treatment with iNKT Cell Ligand α-Galactosylceramide Confers a Long-term Protection Against Lupus
Jun-Qi Yang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Metabolic Disturbances Associated with Systemic Lupus Erythematosus
Tianfu Wu et al.
PLOS ONE (2012)
Acid sphingomyelinase in macrophage biology
Jean-Philip Truman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Exogenous Ceramide-1-phosphate Reduces Lipopolysaccharide (LPS)-mediated Cytokine Expression
Jody L. Hankins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Transcriptional repression of ceramide kinase in LPS-challenged macrophages
Philipp Rovina et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Ceramide and Ceramide 1-Phosphate Are Negative Regulators of TNF-α Production Induced by Lipopolysaccharide
Szczepan Jozefowski et al.
JOURNAL OF IMMUNOLOGY (2010)
An update on sphingosine-1-phosphate and other sphingolipid mediators
Henrik Fyrst et al.
NATURE CHEMICAL BIOLOGY (2010)
Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?
Y. Ilan
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-α and induces interleukin-10 production in activated macrophages
Meir Goldsmith et al.
IMMUNOLOGY (2009)
Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: A case report
Ramji Gupta et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2009)
Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages
Jeniter E. Hughes et al.
CIRCULATION RESEARCH (2008)
Integration of metabolism and inflammation by lipid-activated nuclear receptors
Steven J. Bensinger et al.
NATURE (2008)
TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells
Tom A. Barr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
William L. Holland et al.
CELL METABOLISM (2007)
The metabolism and function of sphingolipids and glycosphingolipids
S. Lahiri et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Toll-like receptors in systemic autoimmune disease
Ann Marshak-Rothstein
NATURE REVIEWS IMMUNOLOGY (2006)
A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products
Kimberly A. Walton et al.
JOURNAL OF LIPID RESEARCH (2006)
Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling
CE Chalfant et al.
JOURNAL OF CELL SCIENCE (2005)
The role of sphingosine and ceramide kinases in inflammatory responses
T Baumruker et al.
IMMUNOLOGY LETTERS (2005)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
Repeated α-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatisis in MRL-lpr/lpr mice
JQ Yang et al.
JOURNAL OF IMMUNOLOGY (2003)